C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus - Wikidata - awgldk - TriplyDB

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

http://www.wikidata.org/entity/Q28241260

about

Diabetes treatment: A rapid review of the current and future scope of stem cell research Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-Analysis An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass Targeting Homeostatic T Cell Proliferation to Control Beta-Cell Autoimmunity New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity Stem cell therapy to cure type 1 diabetes: from hype to hope.Immune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experience SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking Type 1 diabetes Risk factors and primary prevention trials for type 1 diabetes Stem cell therapy for diabetes mellitus Concise review: pancreas regeneration: recent advances and perspectives Concise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 Diabetes Current progress of human trials using stem cell therapy as a treatment for diabetes mellitus Type 1 diabetes: translating mechanistic observations into effective clinical outcomes Bone marrow derived stem cell therapy for type 2 diabetes mellitus Evolving pandemic diabetic nephropathy Residual β-Cell Function Predicts Clinical Response After Autologous Hematopoietic Stem Cell Transplantation.Cytosine methylation dysregulation in neonates following intrauterine growth restriction.Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus Stem cell transplantation for autoimmune diseases.Bone marrow-derived stem cell transplantation for the treatment of insulin-dependent diabetes.Autografting of bone marrow mesenchymal stem cells alleviates streptozotocin‑induced diabetes in miniature pigs: real-time tracing with MRI in vivo.Immunotherapy of type 1 diabetes: where are we and where should we be going?The road not taken: a path to curing type 1 diabetes?Stem cells as a therapeutic target for diabetes.Therapeutic doses of multipotent stromal cells from minimal adipose tissue Efforts to prevent and halt autoimmune beta cell destruction.Acute response of peripheral blood cell to autologous hematopoietic stem cell transplantation in type 1 diabetic patient.Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients.Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials.Efficacy and safety of autologous bone marrow derived hematopoietic stem cell transplantation in patients with type 2 DM: A 15 months follow-up study Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons.Stem cell-based strategies for the treatment of type 1 diabetes mellitus Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man.Stem cells in clinical practice: applications and warnings.Methods to assess stem cell lineage, fate and function Use of a precious resource: parental decision making about using autologous umbilical cord blood in studies involving young children with type 1 diabetes.Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?Progressive erosion of β-cell function precedes the onset of hyperglycemia in the NOD mouse model of type 1 diabetes.

P2860

Q26748645-9BE79CDC-AE69-45CF-9520-15DB3842C40E Q26748676-0AFA93E3-8590-4F8A-998D-9ECC72B42FD4 Q26749089-CA9B8D50-38DB-48AB-BD05-922F7A720F5D Q26764999-1A4935F2-A659-4329-9E44-A4A4116D5DE2 Q26823090-D1CD0477-8CFE-4466-BBD7-9C3F0CE44BB6 Q26823294-8DD4208A-8FB3-47BC-B3F4-D52E0CC50C5B Q26850621-0BA69836-0D07-43BB-93D3-05EAFBA30D94 Q26853573-5E8EF51C-1164-4C95-B15A-851D31CA975C Q27000491-E6A4B916-E078-491E-A5F0-E1EFF62ED7B1 Q27005625-6C5BAAAC-64D6-476A-8669-DA4D566E498A Q27011453-212A2CDF-761B-4814-9CDA-6766D5A182DC Q27013646-4C1E6472-03B7-4634-AC78-133E638235B6 Q28071490-DB2A7D90-5DF6-4416-BF89-1437BBC12E8A Q28078407-9D23F4AC-2E1B-4A43-97DE-3B6E9C2C994B Q28287737-AA5FB20B-6062-4F2E-9EE6-B19F904D6CB7 Q28354170-7689BF12-86B5-451F-BFF2-8E02FD993397 Q30352538-79F48FB2-BD47-4089-834B-2A11655E57E1 Q30743822-7A252405-4898-419D-A458-80465DF53759 Q33528945-7B9713A9-B6F3-41BB-9D1E-C86DF639D7A8 Q33576368-1E87240F-E288-4277-8668-9E86CAF062C2 Q33632194-656C6F24-894B-4137-9973-B010DFFE14F7 Q33742259-D18DC384-F653-4697-B403-6851A1A55CB2 Q33747741-F23FF5CF-FFC7-4B3B-BD15-36E367D09BF0 Q33815506-6647DD7B-8D21-4562-976E-F866B5C37A73 Q33859301-28662BB2-1DF1-48AD-ACED-3C28EC20D50C Q33982394-F9BC9F09-FCB6-46AC-8DF0-EFBCAD2C5B12 Q34023110-18D6638E-064F-4436-83D5-82673C253E59 Q34077363-DF91B9B4-6101-4CB7-A647-A782E2D3E258 Q34182038-D6EAE8A7-214B-4F3C-B6D3-E492197C339F Q34244112-4F149A58-B5C6-4EB2-AA48-4EF1D5AED0F0 Q34318993-05576A84-2521-43FC-BBA9-8BF2DEC4E379 Q34319707-F4B47571-1B39-41C7-988C-6930BA651604 Q34375578-8658B360-4645-4CF0-992D-193E7E196825 Q34417324-28BA0B56-D5A9-444D-BB8A-1512ABF7815E Q34448607-F8C462A6-A848-47EE-BE75-EC1904EE5D43 Q34552765-A0E56E10-4DEB-426A-8154-030B1BA465F3 Q34807143-472C632E-33D7-4819-98F4-9596DDF970E8 Q35086582-B59FD937-DAF9-49AF-A838-04DC870E1033 Q35116303-0A570207-F0BE-496E-9B25-AC04869478E4 Q35123531-7FC4CC2C-F3BE-4A45-9213-E43DDC65AB22

P2860

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

http://www.wikidata.org/entity/Q28241260

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

C-peptide levels and insulin i ...... nosed type 1 diabetes mellitus

@ast

C-peptide levels and insulin i ...... nosed type 1 diabetes mellitus

@en

C-peptide levels and insulin i ...... nosed type 1 diabetes mellitus

@nl

type

label

C-peptide levels and insulin i ...... nosed type 1 diabetes mellitus

@ast

C-peptide levels and insulin i ...... nosed type 1 diabetes mellitus

@en

C-peptide levels and insulin i ...... nosed type 1 diabetes mellitus

@nl

prefLabel

C-peptide levels and insulin i ...... nosed type 1 diabetes mellitus

@ast

C-peptide levels and insulin i ...... nosed type 1 diabetes mellitus

@en

C-peptide levels and insulin i ...... nosed type 1 diabetes mellitus

@nl

P1433

Q28241260-3EA81366-2EBD-45CA-8934-C0ABF357FB08

P1476

Q28241260-CE1F8EE6-85E3-41EF-B739-E1F858076126

P2093

Q28241260-1431798C-D8AE-4A5D-B7D1-DB29B1B1F5AA

Q28241260-30F4DA20-C2C1-484D-8B89-B6A149354D90

Q28241260-4EC63436-C816-4F14-8985-747A60AF3B4B

Q28241260-A80B52FF-7201-4510-B938-B42CC38A3D3A

Q28241260-CAB60944-72D1-4F01-9A2F-3B692542D303

Q28241260-D79E24AD-0C9C-410B-9591-F9174BB5D293

Q28241260-D8AB5C3F-3B01-415D-8B86-1C96019D8EFB

Q28241260-E45A3018-4C05-4E17-AD71-62EC40A01490

Q28241260-E699CEB0-6791-4FEC-8C49-898EB7ABB754

Q28241260-F5833AA7-2D77-4859-9E85-B695F9A3211D

P304

Q28241260-94C0EF89-9D70-466B-BB2A-3F5449635B8F

P31

Q28241260-297684DC-8AEC-4E4A-86A9-83C09FC35850

P3181

Q28241260-E6601E14-3967-46E9-A6C9-279964D77C84

P356

Q28241260-91774DDA-E0F5-46D2-9B70-EF6160D5708D

P407

Q28241260-F2582776-49DE-4369-B50A-341A8A82A43F

P433

Q28241260-5E3C00B4-2158-4C11-873B-99927F3F8DD0

P478

Q28241260-F97277FF-2A5B-4416-B4AC-6CE2FEF88300

P50

Q28241260-658CB309-5C63-435C-B373-B8F735A9944D

Q28241260-7BD0B033-EC34-4A0B-9201-4196E520BC3D

Q28241260-7BEBFB86-E65F-4DE9-839F-FF653E3110EB

Q28241260-B6917F4B-9722-4945-957D-4CD1C64AE504

P577

Q28241260-BA4E9AAA-D062-4482-80ED-805F7B6CE9E4

P5875

Q28241260-9B489481-5909-4650-A312-BEC01114759B

P698

Q28241260-77B8D0D5-8913-4D0A-8F59-3D5BF45DCE54

P921

Q28241260-4B3A168D-21BD-4872-A901-B78E1791F659

Q28241260-A9A18C40-0940-455A-87E4-8AA6142BC4BC

P3181

P356

P1433

Journal of the American Medical Association

P1476

C-peptide levels and insulin i ...... nosed type 1 diabetes mellitus

@en

P2093

Ana B P L Stracieri

http://www.w3.org/2001/XMLSchema#string

Carlos E B Couri

http://www.w3.org/2001/XMLSchema#string

Daniela A Moraes

http://www.w3.org/2001/XMLSchema#string

Fabiano Pieroni

http://www.w3.org/2001/XMLSchema#string

George M N Barros

http://www.w3.org/2001/XMLSchema#string

Júlio C Voltarelli

http://www.w3.org/2001/XMLSchema#string

Maria C B Oliveira

http://www.w3.org/2001/XMLSchema#string

Maria Isabel A Madeira

http://www.w3.org/2001/XMLSchema#string

Milton C Foss

http://www.w3.org/2001/XMLSchema#string

Richard K Burt

http://www.w3.org/2001/XMLSchema#string

P304

1573-1579

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1960590

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/JAMA.2009.470

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

301

http://www.w3.org/2001/XMLSchema#string

P50

Edson Zangiacomi Martinez

Maria C Foss-Freitas

Kelen Cristina Ribeiro Malmegrim

Belinda Pinto Simoes

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24277923

http://www.w3.org/2001/XMLSchema#string

P698

19366777

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes